Please login to the form below

Not currently logged in

Sophia Genetics appoints CFO

Valentin Matillon joins firm from the Hobart Group

Data-driven medicine firm Sophia Genetics has appointed its new chief financial officer in the form of Valentin Matillon.

He brings over two decades worth of experience in senior financial management positions to the group, holding roles in technology organisations including SITA, Hewlett-Packard and Electronic Arts.

He said: “Our ground breaking technology and approach are revolutionising the healthcare field, improving the prognosis of patients worldwide and I look forward to supporting the company through its journey of growth and development.”

Matillon joins Sophia Genetics from the Hobart Group, where he served as senior director of finance.

His new role will see him take responsibility for the company’s finance and accounting functions.

Jurgi Camblong, chief executive officer and co-founder of Sophia Genetics, said: “Matillon’s track record in transforming finance functions and supporting new acquisitions, along with his pragmatic and results-driven approach, make him a natural fit for the fast-paced culture of Sophia Genetics.”

19th January 2018

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?
The Biosimilar Challenge